Page last updated: 2024-10-22

amitriptyline and Respiratory Tract Diseases

amitriptyline has been researched along with Respiratory Tract Diseases in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bek, K1
Ozkaya, O1
Mutlu, B1
Dağdemir, A1
Sungur, M1
Açikgöz, Y1
Işlek, I1
Baysal, K1

Other Studies

1 other study available for amitriptyline and Respiratory Tract Diseases

ArticleYear
Charcoal haemoperfusion in amitriptyline poisoning: experience in 20 children.
    Nephrology (Carlton, Vic.), 2008, Volume: 13, Issue:3

    Topics: Acute Disease; Adolescent; Amitriptyline; Antidepressive Agents, Tricyclic; Antidotes; Charcoal; Chi

2008